Studies in larger and independent cohorts are needed to confirm these findings and to determine whether and to which degree other GDM-related parameters such as maternal pBMI and its associated biochemical alterations (circulating cytokines, blood lipid profiles, etc.)influence placental SLC6A4 methylation and expression. Here, SLC6A4 is linked to gestational diabetes.